JPRN-UMIN000042873已完成未知
Open-label crossover trial for the efficacy and safety of switching to HIF-PH inhibitor in anemic patients with maintenance hemodialysis treated by ESA. - HIF-PH anemia study
akajima tsuchiya clinic0 个研究点目标入组 40 人开始时间: 2021年1月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who have difficulty in taking oral medicine. 2.Patients on concomitant peritoneal dialysis. 3.Patients judged by the investigator to be unsuitable as subjects.
研究者
相似试验
进行中(未招募)
1 期
Trial to investigate the efficacy of treatments in apomorphine-induced skin reactionsParkinson's diseaseEUCTR2014-000657-36-NLniversity Medical Center Groningen20
进行中(未招募)
1 期
An open-label randomized trial of zanidatamab for advanced HER2positive biliary tract cancerCTIS2023-508219-21-00Jazz Pharmaceuticals Ireland Limited243
尚未招募
3 期
An open-label randomized trial of zanidatamab for advanced HER2-positive biliary tract cancerCTRI/2024/08/072371Jazz Pharmaceuticals Ireland Limited
进行中(未招募)
不适用
Open-label, non-Controlled Trial on Efficacy and Safety in Prevention and On-demand Treatment of Bleeding Episodes in Previously Treated Patients of N8 in with Haemophilia A.Sub-trial Efficacy and Safety of N8 in Prevention and Treatment of Bleeding during Surgical Procedures in Patients with Haemophilia A - NDHeamophilia AMedDRA version: 12.0Level: LLTClassification code 10018937Term: Haemophilia AEUCTR2008-003960-20-ITOVO NORDISK140
已完成
不适用
An open-label, crossover study to assess the pharmacokinetics, safety and tolerability of pulsatile intra-vaginal delivery of insulin aspart in females with diabetes mellitus type 1PK of Insulin10018424NL-OMON51108iGalli BV8
